Outset Medical, Inc. (NASDAQ:OM) Stock Has Consensus Target Price of $10.00

Outset Medical, Inc. (NASDAQ:OM) has received a consensus rating of “Hold” from the five analysts that are covering the company, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and three have issued a buy recommendation on the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $10.00.

Several research firms have recently issued reports on OM. Wall Street Zen upgraded Outset Medical from a “sell” rating to a “hold” rating in a research report on Saturday, August 15th. Weiss Ratings lowered shares of Outset Medical from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Friday, August 21st.

Hedge Funds Weigh In On Outset Medical

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Bank of New York Mellon Corp raised its position in shares of Outset Medical by 4.1% during the first quarter. Bank of New York Mellon Corp now owns 62,360 shares of the company’s stock worth $239,000 after purchasing an additional 2,435 shares during the period. Sei Investments Co. increased its stake in Outset Medical by 15.5% during the 1st quarter. Sei Investments Co. now owns 35,366 shares of the company’s stock worth $136,000 after purchasing an additional 4,738 shares in the last quarter. R Squared Ltd bought a new stake in Outset Medical during the 1st quarter worth approximately $65,000. Squarepoint Ops LLC bought a new stake in Outset Medical during the 2nd quarter worth approximately $98,000. Finally, Marquette Asset Management LLC bought a new stake in shares of Outset Medical during the second quarter worth $212,000.

Outset Medical Stock Performance

Outset Medical stock opened at $4.02 on Tuesday. The company has a market cap of $75.58 million, a PE ratio of -0.98 and a beta of 1.99. The company has a current ratio of 5.19, a quick ratio of 4.11 and a debt-to-equity ratio of 1.03. Outset Medical has a 1 year low of $2.84 and a 1 year high of $13.28. The company’s 50-day moving average is $3.72 and its two-hundred day moving average is $4.16.

Outset Medical (NASDAQ:OM) last announced its quarterly earnings data on Thursday, August 6th. The company reported ($0.80) earnings per share for the quarter, missing the consensus estimate of ($0.72) by ($0.08). The business had revenue of $31.64 million during the quarter, compared to analyst estimates of $28.97 million. Outset Medical had a negative net margin of 63.06% and a negative return on equity of 61.67%. Equities analysts anticipate that Outset Medical will post -3.81 earnings per share for the current year.

Outset Medical Company Profile

Outset Medical, Inc is a medical technology company that develops products for hemodialysis, a treatment that filters waste and excess fluid from the blood when the kidneys are no longer able to do so adequately. The company’s primary product is the Tablo Hemodialysis System, an integrated dialysis platform designed to simplify treatment for healthcare providers and support broader use of dialysis in hospitals, outpatient facilities and the home.

The Tablo system combines dialysis delivery, water purification and dialysate production in a single device and uses a touchscreen interface intended to guide users through treatment setup and operation.